Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Numab Therapeutics
Biotech
Biotechs behind J&J-bought Yellow Jersey partner on IBD drug
After seeing success with the acquisition of Yellow Jersey by J&J this year, Kaken and Numab have signed another inflammation-focused collaboration.
James Waldron
Nov 15, 2024 8:30am
J&J scoops up another atopic dermatitis drug for $1.25B
May 28, 2024 8:30am
Ono inks deal for antibody against ‘very challenging’ I-O target
Mar 31, 2022 7:58am
Numab raises $111M to challenge Genmab for new PD-L1 opportunity
May 20, 2021 3:00am
Vasella helps Numab to CHF22M round ahead of cancer trial start
Mar 9, 2020 7:00am
